Christopher B Hopson

Title: Christopher B Hopson: Innovator in Antigen Binding Proteins

Introduction

Christopher B Hopson, an accomplished inventor based in Collegeville, Pennsylvania, has made significant contributions to the field of biomedical innovation. With one patent to his name, he has focused his work on antigen binding proteins, which have potential applications in treating various cancers.

Latest Patents

Hopson's notable patent revolves around antigen binding proteins, including antibodies that specifically target HER3. This disclosure encompasses polynucleotides encoding these proteins, pharmaceutical compositions that include them, as well as methods for their manufacture. The potential clinical applications are expansive, aiming to aid in the treatment or prevention of diseases such as breast cancer, ovarian cancer, prostate cancer, bladder cancer, pancreatic cancer, gastric cancer, melanoma, and other cancers that overexpress HER3.

Career Highlights

Christopher B Hopson is associated with GlaxoSmithKline Intellectual Property Development Limited, where he leverages his expertise to drive forward innovative solutions in the pharmaceutical domain. His research and inventions reflect a commitment to addressing critical health issues faced by patients.

Collaborations

Throughout his career, Hopson has collaborated with esteemed colleagues, including Neil James Clarke and Kyung Oh Johanson, further enhancing the collaborative nature of research and invention within the industry. These partnerships contribute to a broader understanding and advancement in the field of medical therapeutics.

Conclusion

With his pioneering spirit and dedication to medical innovation, Christopher B Hopson continues to contribute significantly to the advancement of therapies that could benefit cancer patients. His work exemplifies the vital role inventors play in developing solutions that address pressing health challenges.